Outcomes of older adults and frail patients receiving idecabtagene vicleucel: a CIBMTR study.
Othman Salim Akhtar, Temitope Oloyede, Ruta Brazauskas, Aimaz Afrough, Hamza Hashmi, Surbhi Sidana, Nausheen Ahmed, Matthew Bye, Doris Hansen, Christopher Ferreri, Binod Dhakal, Devender Dhanda, Melanie Harrison, Amani Kitali, Heather Landau, Abu-Sayeef Mirza, Jinalben Patel, Pallavi Patwardhan, Muzaffar Qazilbash, Krina Patel, Taiga Nishihori, Siddhartha Ganguly, Lohith Gowda, Larry D Anderson, Marcelo C Pasquini, Saad Usmani, Ciara Louise Freeman
Author Information
- Othman Salim Akhtar: Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
- Temitope Oloyede: Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
- Ruta Brazauskas: Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
- Aimaz Afrough: Department of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.
- Hamza Hashmi: Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.
- Surbhi Sidana: Department of Medicine, Stanford University School of Medicine, Stanford, CA. ORCID
- Nausheen Ahmed: Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS. ORCID
- Matthew Bye: Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
- Doris Hansen: Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.
- Christopher Ferreri: Atrium Health/Levine Cancer Institute, Charlotte, NC.
- Binod Dhakal: Department of Medicine, Medical College of Wisconsin, Milwaukee, WI. ORCID
- Devender Dhanda: Bristol Myers Squibb, Lawrence Township, NJ.
- Melanie Harrison: Bristol Myers Squibb, Lawrence Township, NJ.
- Amani Kitali: Bristol Myers Squibb, Lawrence Township, NJ.
- Heather Landau: Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY. ORCID
- Abu-Sayeef Mirza: Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.
- Jinalben Patel: Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY. ORCID
- Pallavi Patwardhan: Bristol Myers Squibb, Lawrence Township, NJ.
- Muzaffar Qazilbash: Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX.
- Krina Patel: Department of Medicine, Medical College of Wisconsin, Milwaukee, WI. ORCID
- Taiga Nishihori: Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL. ORCID
- Siddhartha Ganguly: Department of Medicine, Baylor College of Medicine, Houston, TX.
- Lohith Gowda: Department of Medicine, Yale Cancer Center, New Haven, CT.
- Larry D Anderson: Department of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX. ORCID
- Marcelo C Pasquini: Department of Medicine, Medical College of Wisconsin, Milwaukee, WI. ORCID
- Saad Usmani: Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.
- Ciara Louise Freeman: Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL. ORCID
No abstract text available.
